InsiderClue
Insiders · Profile

Fox Christine

EVP, U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES. Filing since 20 Nov 2024. CIK 0001998173

Company
Date
Role
Action
Shares
Amount
Of holding
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
30 Apr 2026
EVP, U.S. Commercial
Sold at will
21,258
$750.62K
25.0%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
5 Mar 2026
EVP, U.S. Commercial
Sold on a plan
7,924
$250.94K
8.5%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
4 Mar 2026
EVP, U.S. Commercial
Sold on a plan
9,098
$295.36K
10.8%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
20 Nov 2025
EVP, Head of U.S. Commercial
Sold on a plan
28,229
$699.52K
30.7%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
14 Nov 2025
EVP, Head of U.S. Commercial
Sold at will
30,000
$753.32K
51.4%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
5 Mar 2025
EVP, Head of U.S. Commercial
Sold on a plan
2,147
$34.17K
3.5%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
4 Mar 2025
EVP, Head of U.S. Commercial
Sold on a plan
4,034
$63.47K
6.2%
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
20 Nov 2024
EVP, Head of U.S. Commercial
Sold on a plan
19,388
$327.09K
30.5%
8 decisions on file.